Cándido Díaz‐Lagares

Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases

R. Pérez-Álvarez, M. Pérez-de-Lis, Cándido Díaz‐Lagares et al. · Seminars in Arthritis and Rheumatism · 2011 · 296 citations · Full text

Inflammation, Antifibrotic Therapy, Inflammatory Lung Disease +12

Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.

Manuel Ramos‐Casals, Francisco José García Hernández, E de Ramón et al. · PubMed · 2010 · 140 citations

Cardiovascular risk factors in primary Sjögren's syndrome: a case-control study in 624 patients

M. Pérez-de-Lis, Miriam Akasbi, P. Díez-Cascón et al. · Lupus · 2010 · 92 citations

Monoclonal gammopathy related to Sjögren syndrome: A key marker of disease prognosis and outcomes

Pilar Brito‐Zerón, Soledad Retamozo, Myriam Gandía et al. · Journal of Autoimmunity · 2012 · 88 citations · Full text

Rheumatoid Disorder, Rheumatology, Sjögren Syndrome +12

Life-Threatening Cryoglobulinemic Patients With Hepatitis C

Soledad Retamozo, Cándido Díaz‐Lagares, Xavier Bosch et al. · Medicine · 2013 · 81 citations

Glomerulonephritis, Hcv Patients, Hepatology +15